HOLX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Hologic Inc (HOLX) is not a strong buy for a beginner, long-term investor at this moment. The stock lacks clear positive catalysts, has mixed financial performance, and recent analyst downgrades suggest limited upside potential. While hedge funds are buying, the technical indicators and options data do not strongly support an immediate entry.
The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 47.671, showing no clear trend. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading close to its pivot point of 74.872, with limited upside resistance at R1: 75.163 and R2: 75.342.
Hedge funds are significantly increasing their positions, with a 4616.24% rise in buying activity over the last quarter. Gross margin improved to 57.21%, up 1.53% YoY.
Options data reflects bearish sentiment, and there are no recent news or event-driven catalysts.
In Q1 2026, revenue increased by 2.54% YoY to $1.0478 billion, but net income dropped by -10.90% YoY to $179.1 million. EPS also declined by -9.20% YoY to 0.79. Gross margin improved slightly to 57.21%, up 1.53% YoY.
Evercore ISI downgraded HOLX to In Line from Outperform with a price target of $78 (down from $79). BNP Paribas Exane also downgraded HOLX to Neutral from Outperform with a $79 price target. These downgrades suggest limited upside potential.
